About
4,155.00JPY+185.00 +4.66%
Closed • Updated at 05:16 GMT+00:00Market Cap$1.07B
P/E Ratio12.54
Volume338.2K
Beta0.58
RSI44.11
Gross Margin47.04%
Kissei Pharmaceutical Co., Ltd. — investor relations, events, news, and company updates on 6ix.
Latest News
Oct 7 2025
Apotex Strengthens Commitment to Women's Health with Exclusive Canadian Rights to "Linzagolix" for Uterine Fibroid Treatment
Aug 6 2025
Viridian Therapeutics Highlights Recent Progress and Reports Second Quarter 2025 Financial Results
Aug 5 2025
Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update
Jul 30 2025
Viridian Therapeutics Announces Collaboration and License Agreement with Kissei Pharmaceutical to Develop and Commercialize Veligrotug and VRDN-003 in Japan with an Upfront Payment of $70 Million and up to $315 Million in Milestone Payments
Community Chat
Ask AI
Try asking
Translate